Phase I Clinical Trial of EA4017: Clinical Pharmacology Study in Healthy Adult Male Subjects
Latest Information Update: 14 Dec 2021
At a glance
- Drugs EA 4017 (Primary)
- Indications Peripheral nervous system diseases
- Focus Therapeutic Use
- Sponsors EA Pharma
- 03 Feb 2021 New trial record